Stock·NASDAQ·Technology
Texas Instruments Inc. (TXN)
- Market cap
- $252.49B
- P/E
- 43.54
- Dividend yield
- 2.05%
- Street target
- $340.00median of 36 analysts
- 52-week range
- $152.73 $334.03
The short version
Where TXN stands today, in four lines, and what CleaRank Financial AI makes of it.
TXN at a glance
Texas Instruments Inc. (TXN): Buy, 65/100 on CleaRank's AI score.
- Trend Up: the price is above both its 50- and 200-day moving averages ($272.30 and $254.27).
- Earnings TXN beat estimates in 5 of its last 6 quarters, yet fell the next day after 3 of those beats.
- Insiders Insiders sold $119.3M and made no open-market purchases over the last 18 months.
- Valuation P/E of 43.5 against 35.1 for the Technology sector: a premium to peers (+24%).
Figures as of October 17, 2026.
CleaRank Financial AI
TXN, or Texas Instruments Inc., receives a Buy rating from CleaRank with a model score of 65/100.
Trend is the strongest lift: the price sits 8.73% above its 200-day average and 1.53% above its 50-day average, and the 50-day average is 7.09% above the 200-day. Valuation pulls the score down most. The P/E of 43.54 is 24.1% above the sector median, a premium to peers, and the P/S of 13.10 is 72.4% above the sector median. The 50-day average is $272.30 and the 200-day is $254.27. Across the past year, the price climbed 57.56%.
Only on CleaRank
Figures we compute ourselves from TXN's own price, earnings and insider-filing history. Tap one to see it in context.
Price and trading
The chart, today's range and how far the price has moved over each period.
Trend checks
4/4Price above its 50-day average ›
The price of $276.48 is 1.5% above the 50-day simple moving average of $272.30.Price above its 200-day average ›
The price is 8.7% above the 200-day simple moving average of $254.27.50-day average above the 200-day ›
The 50-day average ($272.30) is 7.1% above the 200-day average ($254.27), the arrangement of a rising longer-term trend.In the upper half of its 52-week range ›
The price sits at 68% of its 52-week range, between $152.73 and $334.03.
TXN share price
Pick a period: each tab shows how far TXN has moved over it, to the last close.
Today's trading
Where TXN sits inside today's range and its 52-week range.
Fundamentals
Valuation against the sector, and the revenue and earnings behind it.
Valuation and quality checks
3/5P/E below the sector median ›
The trailing P/E of 43.54 is 24.1% above the Technology median of 35.1.P/S below the sector median ›
The price-to-sales ratio of 13.10 is 72.4% above the sector median of 7.6.Profitable over the last 12 months ›
Net income over the last 12 months was $6.0B on revenue of $19.5B, a net margin of 30.9%.Beat estimates in most recent reports ›
TXN beat the EPS estimate in 5 of its last 6 reports.Pays a dividend ›
The trailing dividend yield is 2.05%, or $5.68 a share a year.
Key statistics
The headline figures for TXN.
As of October 17, 2026, TXN trades at $276.48, with a market value of $252.49B, a P/E ratio of 43.54 and a dividend yield of 2.05%.
What the numbers say
CleaRank Financial AI's reading of TXN's valuation, growth and risks.
Texas Instruments Inc. (TXN) trades on a trailing P/E of 43.54, against a Technology median of 35.1. That leaves the P/E 24.1% above the sector median, and the peer comparison on this page calls it a premium to peers. Its price-to-sales ratio of 13.10 is 72.4% above the sector median of 7.6. Market capitalisation stands at $252.5B, and trailing earnings are $6.41 a share.
TXN's growth lags the sector: revenue expanded 22.80% in the latest year, while the sector median is 24.2%. The company converts revenue into a 31.11% net margin and a 42.58% operating margin. Return on equity stands at 35.18%, which is above the sector median of 13.4%. On the balance sheet, debt-to-equity is 0.78, and the trailing dividend yield of 2.05% works out to $5.68 per share each year.
TXN's most recent earnings report, released on July 22, 2026, topped expectations by 10.31%. EPS came in at $2.14, compared with the $1.94 analysts had penciled in. The share price nonetheless slipped 3.13% in the first session after the report.
TXN beat estimates in 5 of the last 6 reports, yet a beat has not reliably lifted the shares: the stock fell the session after 3 of those 5 beats. The sharpest earlier reaction followed the July 22, 2025 report, where EPS beat the estimate by 6.02% but the stock dropped 13.34%. Analysts forecast EPS of $8.50 for this fiscal year, a rise of 56.0%, and $10.13 for the next, a rise of 19.2%.
At a P/E of 43.54, which is 24.1% above the sector median, TXN is a premium to peers, so any shortfall in results would be judged against a demanding bar. The 30-day standard deviation of TXN's daily returns is 1.74%. The price sits 17.23% below its 52-week high of $334.03. Over the last 18 months insiders sold $119.3M of stock and bought none on the open market. Sales like these are often planned ahead, so they carry less weight than purchases would.
TXN against the Technology sector
How TXN compares with the median Technology stock CleaRank tracks.
Price to earnings vs sector: TXN trades at a significant premium to sector peers (+24%), suggesting market expectations for superior growth or market position.
Return vs XLK: Since May 6, 2025, TXN has gained 71.6% against a gain of 73.7% for XLK.
Performance against XLK
TXN and the Technology sector fund over the same days.
Revenue and earnings
How much TXN sells, and how much of it becomes profit.
Revenue growth: Revenue grew 13.0% in FY2025 to $17.7B, from $15.6B a year earlier.
Profit margin: The net margin was 28.3% in FY2025, down from 30.7% the year before.
Profitable: TXN earned $5.0B in FY2025.
Earnings reality check
Did TXN beat what analysts expected, and how did the stock react?
Earnings record: TXN beat the analyst estimate in 5 of the last 6 quarters.
Market reaction: The stock fell in the first session after 3 of those 5 beats, so a beat has not been enough on its own.
| Report | Estimate | Actual | Surprise | First session | 5 sessions |
|---|---|---|---|---|---|
| Jul 22, 2026after close | $1.94 | $2.14 | +10.31% | -3.13% | -7.78% |
| Jan 27, 2026after close | $1.31 | $1.27 | -3.05% | +9.94% | +14.53% |
| Jul 22, 2025after close | $1.33 | $1.41 | +6.02% | -13.34% | -10.95% |
| Apr 23, 2025after close | $1.10 | $1.28 | +16.36% | +6.56% | +5.19% |
| Jan 23, 2025after close | $1.20 | $1.30 | +8.33% | -7.52% | -7.65% |
| Oct 22, 2024after close | $1.37 | $1.47 | +7.30% | +4.01% | +8.96% |
As of October 17, 2026, TXN has beaten the analyst EPS estimate in 5 of its last 6 reported quarters and fell in the first trading session after 3 of those beats; its latest report, on July 22, 2026, came in 10.31% above the estimate and the stock moved -3.13% in the first session.
The first session is the first full trading day on the news: the report day itself for a report before the open, the next day for one after the close. Surprise is actual EPS against the consensus estimate.
AI analysis and technicals
CleaRank's score and reasoning, the indicators behind it, and what the price moves with.
Momentum checks
2/3RSI not overbought or oversold ›
The 14-day RSI is 47.5, in neutral territory.RSI above 50 ›
An RSI of 47.5 is below the 50 midpoint, so sellers have had the upper hand over the last 14 days.MACD line above zero ›
The MACD line is positive, so the 12-day average is above the 26-day average.
CleaRank AI analysis of TXN
The score, the reasoning behind it, and what could move the price next.
Texas Instruments Inc. (TXN) is in an uptrend. The price of $276.48 sits 8.73% above its 200-day average of $254.27 and 1.53% above its 50-day average of $272.30. The 50-day average is also 7.09% above the 200-day, so the two averages point the same way. Over the past year, the price is 81.03% above the 52-week low of $152.73 and 17.23% below the high of $334.03.
Short-term and long-term readings disagree. TXN climbed 6.07% over the last month and 57.56% over the last year, yet slid 2.65% across the past three months. Last session's volume came in 50.5% above its average, even though the price dropped 0.95% that day. With the 14-day RSI at 47.5, momentum sits in the neutral zone, and the MACD line is positive.
Earnings beat ›
The July 22, 2026 report beat the EPS estimate by 10.31%, and the share price fell 3.13% in the first session after it.
Source: Earnings report, July 22, 2026
Rating reaffirmed ›
Cantor Fitzgerald kept its Neutral rating on August 17, 2026.
Source: Analyst action, Cantor Fitzgerald, August 17, 2026
- Keep an eye on the two closest levels. The 20-day EMA at $280.38 lies above the price, and the 50-day SMA at $272.30 lies below it.
- A 14-day RSI of 47.5 is neutral, and the MACD line is positive. Readings above 70 or below 30 point to stretched momentum.
- The share price declined 3.13% in the first session after the July 22, 2026 report, even though TXN has beaten estimates in 5 of the last 6 reports.
The uptrend rests on TXN staying above its 50-day average at $272.30 and its 200-day average at $254.27; a close below the 50-day would be the first crack in it. On a pullback, the first level the price would meet is the 50-day SMA at $272.30.
The first hurdle on the way up is the 20-day EMA, currently at $280.38, which sits above the price.
Technical indicators
Momentum and trend for TXN, from its daily closes.
As of October 17, 2026, with TXN at $276.48, its 14-day RSI is 47.5 (neutral territory), its 50-day simple moving average is $272.30 and its 200-day is $254.27.
Calculated by CleaRank on daily closes as of October 17, 2026: Wilder's 14-day RSI, 50- and 200-day simple moving averages, MACD line (12, 26).
What TXN moves with
Correlation of daily returns over one year: +1 moves in step, 0 has no link, -1 moves the opposite way.
As of October 17, 2026, TXN's 1-year correlation of daily returns is +0.55 with S&P 500 (SPY), +0.57 with Nasdaq 100 (QQQ), +0.18 with Bitcoin (BTC) and +0.15 with gold (XAU).
What Wall Street expects
The analysts' target range and how their ratings split.
Analysts checks
3/3Most analysts rate it a buy ›
19 of 36 analysts rate it a buy or strong buy, 15 a hold and 2 a sell.Median target above the price ›
The median 12-month target of $340.00 is 23.0% above the price.More buy ratings than three months ago ›
19 of 36 rate it a buy now, against 18 of 36 three months ago.
TXN Wall Street View
12-month price targets
Ratings
Recent rating actions
| Date | Firm | Action | Rating |
|---|---|---|---|
| Aug 17, 2026 | Cantor Fitzgerald | Reiterates | Neutral |
| Jul 24, 2026 | Rosenblatt | Maintains | Buy |
| Jul 23, 2026 | Bernstein | Maintains | Market Perform |
| Jul 23, 2026 | JP Morgan | Maintains | Overweight |
| Jul 23, 2026 | Morgan Stanley | Maintains | Underweight |
| Jul 23, 2026 | TD Cowen | Maintains | Buy |
As of October 17, 2026, 36 Wall Street analysts cover TXN: 19 rate it a buy or strong buy, 15 a hold and 2 a sell or strong sell. Their 12-month price targets range from $225.00 to $400.00, with a median of $340.00, 23.0% above the price of $276.48.
Source: TwelveData analyst consensus. Targets and ratings belong to the analysts, not to CleaRank.
A trade plan, if you want one
Entry, stop and target levels from the moving averages and recent volatility. Educational, not advice.
TXN trade plan
Entry, stop and target levels, sized to your account. Change the bias or the risk and every level updates.
Long entry pick an entry style
Risk management
Profit targets (Based on Conservative Entry)
These levels come from TXN's moving averages and recent volatility, not from a forecast. Educational levels, not financial advice; the full disclaimer is at the foot of the page.
Risk profile
How much TXN tends to move, against the market and on its own.
The long record
TXN's worst falls and recoveries, what $10,000 became, and which months have been kind to it.
Track record checks
4/4Average daily move under 2% ›
The price has moved 1.74% on an average day (30-day standard deviation of daily returns).Recovered from its worst fall ›
The worst fall was 31.9%, from November 2024 to April 2025, regained by July 2025.Most 1-year holds ended higher ›
74% of 1-year holding periods in the last 10 years ended with a gain.Beat the S&P 500 since the chart begins ›
$10,000 invested in October 2016 is now worth $53,051, against $42,055 in the S&P 500 (SPY).
TXN Drawdowns & Recovery
As of October 17, 2026, TXN's worst peak-to-trough fall over the last 10 years with dividends reinvested was -31.9% (November 2024 to April 2025); it regained that peak by July 2025, 3 months after the low, and 74% of 1-year holding periods ended with a gain.
From weekly closing values with dividends reinvested. A drawdown is the fall from the highest value reached so far to a later low.
Growth of $10,000
What $10,000 put into TXN in October 2016 is worth now, against the same amount in the S&P 500.
Against the market: TXN beat the S&P 500 over this period: $53,051 against $42,055.
A $10,000 investment in TXN in October 2016 would be worth about $53,051 today with dividends reinvested, compared with about $42,055 for the same investment in the S&P 500 benchmark (also with dividends reinvested).
Seasonal patterns
Which calendar months have been kind to TXN, and which have not.
Strongest month, May: an average of +5.12%, up in 9 of 10 years.
Weakest month, October: an average of -3.58%, up in 4 of 9 years.
This month, October: has averaged -3.58%, up in 4 of 9 years. Past seasonality does not repeat on schedule.
Over the last 10 years, TXN's strongest calendar month has been May (average +5.12%, up in 9 of 10 years) and its weakest October (average -3.58%, up in 4 of 9 years).
Average return for each calendar month over the last 10 years, from weekly closing prices with dividends included.
Long-term scenarios
Thousands of simulated paths from the price history. A range of outcomes, not a forecast.
Monte Carlo projection
Thousands of simulated paths for $10,000 in TXN, from its own past volatility. The shaded area holds 80% of them.
CleaRank's 10-year Monte Carlo simulation projects that a $10,000 investment in TXN today could grow to about $24,174 by 2036 in the base case, with a 90th-percentile outcome near $87,558 and a 10th-percentile outcome around $6,674. The simulation models price only; at today's 2.05% yield, dividends would add to these figures. Projections are statistical simulations, not guarantees.
TXN Stock Price Prediction: 2030
The same simulation in share prices, year by year.
CleaRank's simulation projects a price near $394 for TXN by 2030 in the base case, from $276 today (1.4x over 4 years). The 10th-percentile path ends near $174. These are outcomes of a Monte Carlo simulation run on TXN's historical return distribution, not price targets, and they assume no dividends are reinvested.
| Year | 10th percentile | Base case | 90th percentile | range base today |
|---|---|---|---|---|
| 2027 | $201 | $302 | $454 | |
| 2028 | $186 | $330 | $587 | |
| 2029 | $178 | $360 | $729 | |
| 2030 | $174 | $394 | $888 | |
| 2031 | $173 | $430 | $1,068 |
Method: a lognormal simulation of TXN's own volatility and capped historical trend, re-run daily; base case is the median path, the outer columns the 10th and 90th percentiles.
Insider trading
What the people running the company have bought and sold.
TXN insider trading
Shares the company's directors and officers bought and sold, from their own filings.
Month by month
Open-market purchases above the line, sales below.
Insider buying: No insider bought TXN shares on the open market in the last 18 months. Sales are often planned in advance or cover tax on vesting shares, so they say less than purchases would.
As of October 17, 2026, TXN insiders reported 31 open-market sales worth $119.3M and no open-market purchases over the last 18 months; grants and option exercises are not counted.
| Date | Insider | Type | Shares | Value |
|---|---|---|---|---|
| Aug 27, 2026 | Tsedeniya Abraham
Officer
|
Sell | 7.0K | $1.9M |
| Aug 27, 2026 | Tsedeniya Abraham
Officer
|
Option | 1.4K | $108.2K |
| Jul 24, 2026 | Julie C. Knecht
Officer
|
Grant | 7.2K | - |
| May 28, 2026 | Martin S Craighead
Director
|
Sell | 10.0K | $3.2M |
| May 14, 2026 | Rafael R Lizardi
Chief Financial Officer
|
Sell | 47.7K | $14.7M |
| May 14, 2026 | Ahmad Bahai
Officer
|
Sell | 5.0K | $1.5M |
| May 14, 2026 | Ahmad Bahai
Officer
|
Option | 5.0K | $550.8K |
| May 14, 2026 | Rafael R Lizardi
Chief Financial Officer
|
Option | 47.7K | $8.3M |
| May 13, 2026 | Carrie Smith Cox
Director
|
Sell | 8.8K | $2.7M |
| May 13, 2026 | Carrie Smith Cox
Director
|
Option | 8.8K | $947.5K |
| May 11, 2026 | Shanon J Leonard
Officer
|
Sell | 5.0K | $1.5M |
| May 4, 2026 | Haviv Ilan
Chief Executive Officer
|
Sell | 20.0K | $5.6M |
| May 4, 2026 | Haviv Ilan
Chief Executive Officer
|
Option | 20.0K | $1.6M |
| May 1, 2026 | Julie C. Knecht
Officer
|
Sell | 10.0K | $2.8M |
| May 1, 2026 | Julie C. Knecht
Officer
|
Option | 5.4K | $701.9K |
| Apr 30, 2026 | Mark T Roberts
Officer
|
Sell | 28.1K | $7.9M |
| Apr 30, 2026 | Mark Gary
Officer
|
Sell | 13.7K | $3.8M |
| Apr 30, 2026 | Mark Gary
Officer
|
Option | 13.7K | $1.8M |
| Apr 30, 2026 | Julie C. Knecht
Officer
|
Grant | 175 | - |
| Apr 30, 2026 | Mark T Roberts
Officer
|
Option | 17.8K | $2.1M |
| Apr 29, 2026 | Mohammad Yunus
Officer
|
Sell | 51.1K | $13.8M |
| Apr 29, 2026 | Mohammad Yunus
Officer
|
Option | 51.1K | $8.3M |
| Apr 27, 2026 | Katharine Kane
General Counsel
|
Sell | 6.1K | $1.7M |
| Apr 27, 2026 | Ahmad Bahai
Officer
|
Sell | 3.7K | $982.4K |
| Apr 27, 2026 | Ahmad Bahai
Officer
|
Option | 3.7K | $290.1K |
| Apr 27, 2026 | Katharine Kane
General Counsel
|
Option | 6.1K | $1.0M |
| Apr 24, 2026 | Rafael R Lizardi
Chief Financial Officer
|
Sell | 40.5K | $11.1M |
| Apr 24, 2026 | Shanon J Leonard
Officer
|
Sell | 18.2K | $5.1M |
| Apr 24, 2026 | Amichai Ron
Officer
|
Sell | 18.4K | $5.0M |
| Apr 24, 2026 | Mark A Blinn
Director
|
Sell | 15.0K | $4.2M |
| Apr 24, 2026 | Pamela H Patsley
Director
|
Sell | 4.3K | $1.2M |
| Apr 24, 2026 | Todd M Bluedorn
Director
|
Sell | 4.3K | $1.2M |
| Apr 24, 2026 | Christine Witzsche
Officer
|
Sell | 3.6K | $998.8K |
| Apr 24, 2026 | Tsedeniya Abraham
Officer
|
Grant | 7.2K | - |
| Apr 24, 2026 | Todd M Bluedorn
Director
|
Option | 4.3K | $474.3K |
| Apr 24, 2026 | Shanon J Leonard
Officer
|
Option | 18.2K | $2.9M |
| Apr 24, 2026 | Rafael R Lizardi
Chief Financial Officer
|
Option | 40.5K | $6.9M |
| Apr 24, 2026 | Pamela H Patsley
Director
|
Option | 4.3K | $474.3K |
| Apr 24, 2026 | Amichai Ron
Officer
|
Option | 15.9K | $1.7M |
| Apr 24, 2026 | Christine Witzsche
Officer
|
Option | 3.6K | $389.3K |
| Feb 17, 2026 | Hagop H Kozanian
Officer
|
Sell | 6.8K | $1.5M |
| Feb 11, 2026 | Rafael R Lizardi
Chief Financial Officer
|
Sell | 71.6K | $15.9M |
| Feb 11, 2026 | Mark Gary
Officer
|
Sell | 23.2K | $5.2M |
| Feb 11, 2026 | Ahmad Bahai
Officer
|
Sell | 6.5K | $1.5M |
| Feb 11, 2026 | Ahmad Bahai
Officer
|
Option | 6.5K | $515.2K |
| Feb 11, 2026 | Mark Gary
Officer
|
Option | 12.9K | $1.4M |
| Feb 10, 2026 | Rafael R Lizardi
Chief Financial Officer
|
Option | 64.5K | $8.4M |
| Feb 9, 2026 | Mark T Roberts
Officer
|
Sell | 4.5K | $986.6K |
| Feb 5, 2026 | Mark A Blinn
Director
|
Sell | 3.1K | $696.6K |
| Feb 5, 2026 | Ahmad Bahai
Officer
|
Sell | 3.0K | $670.4K |
| Feb 5, 2026 | Ahmad Bahai
Officer
|
Option | 3.0K | $237.8K |
| Feb 5, 2026 | Mark A Blinn
Director
|
Option | 2.6K | $451.3K |
| Jan 29, 2026 | Ahmad Bahai
Officer
|
Grant | 6.6K | - |
| Jan 29, 2026 | Mark A Blinn
Director
|
Grant | 525 | - |
| Jan 29, 2026 | Todd M Bluedorn
Director
|
Grant | 525 | - |
| Jan 29, 2026 | Janet F Clark
Director
|
Grant | 525 | - |
| Jan 29, 2026 | Carrie Smith Cox
Director
|
Grant | 525 | - |
| Jan 29, 2026 | Martin S Craighead
Director
|
Grant | 525 | - |
| Jan 29, 2026 | Reginald Desroches
Director
|
Grant | 525 | - |
| Jan 29, 2026 | Curtis C Farmer
Director
|
Grant | 525 | - |
| Jan 29, 2026 | Mark Gary
Officer
|
Grant | 11.4K | - |
| Jan 29, 2026 | Jean M Hobby
Director
|
Grant | 525 | - |
| Jan 29, 2026 | Haviv Ilan
Chief Executive Officer
|
Grant | 48.0K | - |
| Jan 29, 2026 | Katharine Kane
General Counsel
|
Grant | 4.8K | - |
| Jan 29, 2026 | Ronald Kirk
Director
|
Grant | 525 | - |
| Jan 29, 2026 | Julie C. Knecht
Officer
|
Grant | 1.3K | - |
| Jan 29, 2026 | Hagop H Kozanian
Officer
|
Grant | 13.5K | - |
| Jan 29, 2026 | Shanon J Leonard
Officer
|
Grant | 5.3K | - |
| Jan 29, 2026 | Rafael R Lizardi
Chief Financial Officer
|
Grant | 12.6K | - |
| Jan 29, 2026 | Pamela H Patsley
Director
|
Grant | 525 | - |
| Jan 29, 2026 | Mark T Roberts
Officer
|
Grant | 12.6K | - |
| Jan 29, 2026 | Amichai Ron
Officer
|
Grant | 13.5K | - |
| Jan 29, 2026 | Robert E Sanchez
Director
|
Grant | 525 | - |
| Jan 29, 2026 | Christine Witzsche
Officer
|
Grant | 4.8K | - |
| Jan 29, 2026 | Mohammad Yunus
Officer
|
Grant | 13.2K | - |
| Nov 26, 2025 | Julie C. Knecht
Officer
|
Grant | 225 | - |
| Nov 26, 2025 | Julie C. Knecht
Officer
|
Grant | 247 | - |
| Nov 24, 2025 | Ronald Kirk
Director
|
Sell | 10.0K | $1.6M |
| Nov 24, 2025 | Ronald Kirk
Director
|
Option | 10.0K | $528.8K |
| Nov 13, 2025 | Christine Witzsche
Officer
|
Sell | 1.0K | $164.3K |
| Nov 13, 2025 | Christine Witzsche
Officer
|
Option | 1.0K | $52.9K |
| Oct 29, 2025 | Richard K Templeton
Chairman of the Board
|
Grant | 2.4K | - |
| Aug 25, 2025 | Ahmad Bahai
Officer
|
Sell | 1.5K | $308.0K |
| Aug 25, 2025 | Ahmad Bahai
Officer
|
Option | 1.5K | $118.9K |
| Aug 25, 2025 | Ahmad Bahai
Officer
|
Grant | 488 | $100.5K |
| Jul 21, 2025 | Mark A Blinn
Director
|
Sell | 0 | $72 |
Source: TwelveData, from SEC Form 4 filings
Questions people ask
Answered from the figures on this page, as of October 17, 2026.